Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis

被引:106
作者
Boletis, JN
Ioannidis, JPA
Boki, KA
Moutsopoulos, HM [1 ]
机构
[1] Univ Athens, Sch Med, Dept Pathophysiol, GR-11527 Athens, Greece
[2] Laikon Gen Hosp, Dept Nephrol, Athens, Greece
[3] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece
[4] Tufts Univ, New England Med Ctr Hosp, Div Clin Care Res, Boston, MA 02111 USA
关键词
D O I
10.1016/S0140-6736(99)01575-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Among 14 randomised patients with proliferative lupus nephritis, monthly intravenous immunoglobulin maintained remission over 18 months, similar to standard intravenous cyclophosphamide treatment. Pulsed immunoglobulin may be a useful alternative therapy in lupus nephritis.
引用
收藏
页码:569 / 570
页数:2
相关论文
共 5 条
[1]   PREDICTING RENAL OUTCOMES IN SEVERE LUPUS NEPHRITIS - CONTRIBUTIONS OF CLINICAL AND HISTOLOGIC DATA [J].
AUSTIN, HA ;
BOUMPAS, DT ;
VAUGHAN, EM ;
BALOW, JE .
KIDNEY INTERNATIONAL, 1994, 45 (02) :544-550
[2]  
AUSTIN HA, 1986, NEW ENGL J MED, V314, P314
[3]   RISK FOR SUSTAINED AMENORRHEA IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS RECEIVING INTERMITTENT PULSE CYCLOPHOSPHAMIDE THERAPY [J].
BOUMPAS, DT ;
AUSTIN, HA ;
VAUGHAN, EM ;
YARBORO, CH ;
KLIPPEL, JH ;
BALOW, JE .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (05) :366-369
[4]  
CORVETTA A, 1989, CLIN EXP RHEUMATOL, V7, P295
[5]  
WINDER A, 1993, J RHEUMATOL, V20, P495